Bank of America’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Bank of America’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2	Closed	–	–	7819
2015 Q4	$0	Buy	+2	New	+$22	﹤0.01%	7783
2014 Q3	–	Sell	-6,090	Closed	-$111K	–	8540
2014 Q2	$111K	Buy	6,090 +6,087	+202,900%	+$104K	﹤0.01%	6062
2014 Q1	$0	Sell	3 -22	-88%	-$637	﹤0.01%	8704
2013 Q4	$1K	Buy	25 +5	+25%	+$168	﹤0.01%	7838
2013 Q3	$1K	Sell	20 -89	-82%	-$4.05K	﹤0.01%	7833
2013 Q2	$5K	Buy	+109	New	+$4.94K	﹤0.01%	7387

Other funds holding KBIO

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of America's KBIO Position: Q1 2016 in Review

Bank of America sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 2 shares.

Bank of America first reported a position in KBIO in Q2 2013 and held it in 6 quarters. The position peaked at $111K in Q2 2014. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

Bank of America reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
Bank of America sold 2 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016.
Bank of America first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 6 quarters.
Bank of America's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $111K in Q2 2014.
1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Bank of America's 13F filing for Q1 2016, filed 13 May 2016.